Clinical trials
Phase 2 Dyslipidemias trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akros Pharma Inc. | 2 |
| Eli Lilly and Company | 2 |
| Kastle Therapeutics, LLC | 2 |
| Akcea Therapeutics | 1 |
| Amgen | 1 |
| Arrowhead Pharmaceuticals | 1 |
| GlaxoSmithKline | 1 |
| NewAmsterdam Pharma | 1 |
| Xention Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 12 |
| Hyperlipidemias | 5 |
| Atherosclerosis | 4 |
| Hypercholesterolemia | 4 |
| Cardiovascular Diseases | 3 |
| Lipid Metabolism Disorders | 3 |
| Metabolic Diseases | 3 |
| Congenital Abnormalities | 1 |
| Genetic Diseases, Inborn | 1 |
| Hyperlipoproteinemias | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.